Term ends Mar 8, 2028 · Medium confidence
20-year base term ended Oct 9, 2022
Why Medium: A parent in the chain could not be resolved.
Held by Novo Nordisk A/S
Filed Nov 5, 2002 as application 10/287,994 · Granted Nov 21, 2006
Base term plus 390 days of patent term adjustment (USPTO delay)
Today
2002
2028
Clock starts
Oct 9, 2002
Oct 9, 2002
Term ends
Mar 8, 2028
Mar 8, 2028
Granted
Nov 21, 2006
Nov 21, 2006
base term
patent term adjustment
fee events
Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
390
Days of term adjustment
Read from the USPTO patent term adjustment record, not recalculated here.
None
Terminal disclaimer
No disclaimer on this record.
3 of 3
Maintenance fees paid
Three maintenance fees fall due, at 3.5, 7.5 and 11.5 years from grant. This counts the ones the record shows paid.
61
Family applications on record here
Applications sharing this one's continuity chain whose file history this site holds. The family may have others.
This patent's term runs 390 days past its 20-year base term on prosecution delay. All three maintenance fees are recorded paid; no more fees are due. Confidence: Medium. from the record
How we calculated this date
One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts Oct 9, 2002, when application PCT/US2002/032263, the earliest non-provisional in its chain, was filed (this one was filed Nov 5, 2002); a parent in its chain could not be resolved (the next row) | Oct 9, 2022 | High confidence |
| Continuity chain | A parent in the chain could not be resolved | dated from this application's own claim | Medium confidence |
| Patent term adjustment | +390 days, USPTO patent term adjustment record | Nov 3, 2023 | High confidence |
| Terminal disclaimer cap | None on record | no cap applied | High confidence |
| Patent term extension | +1587 days, USPTO 35 U.S.C. 156 certificate | added to Nov 3, 2023: Mar 8, 2028 | High confidence |
| Fee events | 3 of 3 maintenance fees paid | In force | High confidence |
| Computed term end | The steps above, in order | Mar 8, 2028 | Medium confidence |
This family
| Application PCT/US2002/032263 | PCT application no patent term | no patent term |
| US 7,138,371 | this patent Mar 2028 | Mar 2028 |
| Application 10/360,770 | Abandoned not computed | not computed |
| Application 10/360,779 | Abandoned not computed | not computed |
| US 7,265,084 | Term ended no later than Dec 2023 | no later than Dec 2023 |
| US 7,795,210 | Lapsed on the fee record Sep 2022 | Sep 2022 |
| US 7,173,003 | Term ended no later than Jan 2024 | no later than Jan 2024 |
| US 7,297,511 | Lapsed on the fee record Nov 2019 | Nov 2019 |
8 of 61 applications in this family shown, earliest filings first. The applications whose file history this site holds. The family may have others.
Assignments
Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| Jan 24, 2003 Reel 13687, frame 76 | Defrees, Shawn; Zopf, David; Bayer, Robert; Bowe, Caryn; Hakes, David; Chen, Xi | Neose Technologies, Inc. | Assignment of Assignor's Interest |
| Feb 23, 2009 Reel 22441, frame 937 | Neose Technologies, Inc. | Novo Nordisk A/S | Assignment of Assignor's Interest |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
What's changing
Mar 2028
Term ends Mar 8, 2028. No further fees fall due before then
Note
The 390 days of patent term adjustment (USPTO delay) are read from the USPTO record, not recalculated by us
Citations
229
later US patents cite this one
That is top 5% of utility patents granted in 2006 in our data, the only group it is compared against.
How we rank
Every date shows its work: the base term, any term adjustment or extension, any disclaimer cap, and the maintenance fee record, each with a confidence tier. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
In force means the term is running and no lapse is on record. It is not a finding that the patent is valid.